Due to endometrial cancer related to metabolic syndrome, the pro-oncogenic effect of TGF-β/Smad is enhanced by lysophosphatidylcholine acyltransferases (LPCATs), a regulator of intracellular lipid metabolism, which promotes cell stemness and metastasis (121). The gene discussed is TGFB1; the disease is endometrial cancer.